Table 3.
Chromosomal abnormality, n (%) | PV | ET | PMF |
---|---|---|---|
+1q | 39/72 (54)* | 13/72 (18) | 20/72 (28) |
12q rearrangement | 2/24 (8) | 1/24 (4) | 21/24 (88)† |
del(17)(p13) | 8/30 (27) | 5/30 (17) | 17/30 (57)‡ |
Incidence of patients who acquired gain of 1q with prior history of PV vs ET, P < .001; PV vs PMF, P = .002.
Incidence of patients who acquired 12q rearrangement with prior history of PMF vs PV, P < .0001; PMF vs ET, P < .0001.
Incidence of patients who acquired del(17)(p13) with prior history of PMF vs PV, P = .02; PMF vs ET, P = .001.